Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.
Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.
MOMA Therapeutics operates as a biotechnology company.
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions.
Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.
Ovid Therapeutic's purpose is to solve intractable medical problems.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
Cormorant Asset Management has invested in 205 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cormorant Asset Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 16 different industry categories.
Among tracked funding rounds, Oruka Therapeutics received $700.4M in a Post-IPO Equity round. Cormorant Asset Management's total known invested capital is $20.8B.
Cormorant Asset Management's average investment size is $136.8M across its portfolio of 205 companies.
Recent Cormorant Asset Management portfolio additions include Icosavax, Quince Therapeutics, Antares Therapeutics, MOMA Therapeutics, Valneva. These companies were founded in 2020 or later.